SAGE Sage Therapeutics Inc. Yalpi foyda bo'yicha marjinallik

Sage Therapeutics Inc. (SAGE) korporativ emblemasi va logotipi

Sage Therapeutics, Inc. (SAGE) Zurzuvae sotuvlarini oshirmoqda va strategik sherikliklar orqali neyrofarmatsevtika sohasidagi ishtirokini kengaytirmoqda. Yangi molekulalarni qidirish avtomatlashtirilgan skriningga asoslangan. GURU.Markets platformasida taxminiy yalpi foyda kapital zichligini namoyish etadi, bunda 89.00 ushbu ko'rsatkichning joriy qiymatini belgilaydi. Biznes suveren siklga tayanadi, bu esa aktivni global makroiqtisodiyotdan mustaqil bo'lgan himoya vositasiga aylantiradi.

Yalpi foyda bo'yicha rentabellik: Sage Therapeutics, Inc. (SAGE) 04.07.2022 - 16.08.2025 uchun

sagerx.com (SAGE) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:SAGE, Sage Therapeutics Inc.
Sage Therapeutics, Inc. yetakchi tovari

Yalpi foyda marjasi dinamikasi bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini aks ettirib, operatsion samaradorlikning asosiy ko'rsatkichi bo'lib xizmat qiladi. Savdo marjalarining tahlili biznesning tushumni o'sish uchun resurslarga aylantirish qobiliyatini baholash imkonini beradi. Sage Therapeutics, Inc. (SAGE) uchun ushbu ko'rsatkich markaziy nerv tizimi (CNS) dori vositalarining tijoratga chiqarilishi davrida juda muhimdir, chunki yangi molekulalar chiqarilishidan oldin tovarlar tannarxini optimallashtirish moliyaviy barqarorlikni belgilaydi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi marja ELYM (eliemtx.com)|intracellulartherapies.com - Yalpi rentabellik|LBPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik NeuroBo Pharmaceuticals|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)